Navigation Links
Research study tests pancreatic cancer drug at Banner MD Anderson Cancer Center

GILBERT, Ariz., Aug. 20, 2015 /PRNewswire/ -- Banner MD Anderson Cancer Center is testing the safety and effectiveness of a drug that, when combined with chemotherapy, may make a difference in treating pancreatic cancer in patients who carry harmful mutations of either the BRCA1 or BRCA2 genes.

Despite recent improvements in treatment options, pancreatic cancer continues to carry a poor prognosis and is the fourth leading cause of cancer deaths in the U.S., according to the National Cancer Institute.

"One of the recent research advances has been the realization that not all of pancreatic cancers are based on same genetic background, and that influences their behavior and response to treatment," said Tomislav Dragovich, MD, PhD, Medical Oncology and Hematology Division Chief at Banner MD Anderson. "Personalizing cancer treatment often involves the option to enroll in a clinical trial."

The trial uses a new class of medications called PARP-inhibitors which are thought to be particularly effective in patients with the BRCA 1/2 mutation. Patients are first treated with a platinum-based chemotherapy regimen and can be included in the study depending on their initial response. The patients are screened for BRCA 1 or 2 mutations and if confirmed, they may be eligible for the trial. The drug is called Olaparib and is manufactured by AstraZeneca.

"About 5 to 6 percent of all pancreatic cancer patients carry the BRCA1 or BRCA2 genes," Dragovich said.

For information about this and other trials, call 480-256-6444 and ask about an appointment with a cancer specialist.

Banner MD Anderson, located on the Banner Gateway campus, delivers cancer care to patients in Arizona through the collaboration of Banner Health and The University of Texas MD Anderson Cancer Center. Banner MD Anderson offers focused disease-specific expertise in the medical, radiation and surgical management of the cancer patient; an evidence-based, multidisciplinary approach to patient care; access to clinical trials and new investigative therapies; state-of-the-art technology for the diagnosis, staging and treatment of all types of cancer; oncology expertise in supportive care services.

Contact: Public Relations

SOURCE Banner MD Anderson Cancer Center
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Catheter Market is Expected to Reach $46.05 Billion By 2020: Grand View Research, Inc.
2. Medical Imaging Equipment Market to Attain Market Value of US$35.35 Billion by 2019: Transparency Market Research
3. DySIS Medical and Unified Womens Clinical Research Announce Research Partnership in Computer-Aided Colposcopy Trial
4. Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market to Reach an Estimated Value of USD 15.9 Billion in 2020: Transparency Market Research
5. Newborn Screening Market To Reach $1.43 Billion By 2022: Grand View Research, Inc.
6. Prescription/Rx Sunglass Market Worth $3.76 Billion By 2022: Grand View Research, Inc.
7. New Data Suggest Downward Trend in Clinical Research Spending
8. CVS Health Research Institute Analysis Shows High Patient Satisfaction with MinuteClinic Telehealth Visits
9. U.S. Army Awards Leidos Medical Research Contract
10. Global Next-Generation Antibody Therapeutics Market is Expected to Grow at 21% CAGR During 2015 - 2020: P&S Market Research
11. Multi-parameter Patient Monitoring Equipment Market Expected to Reach USD 4.7 Billion Globally in 2023: Transparency Market Research
Post Your Comments:
(Date:5/27/2020)... ... ... Focus Technology , a leading provider of next-generation IT infrastructure, managed ... the American Heart Association’s 2020 Boston Heart Walk, earning them the distinction ... is sponsoring the AHA event. The sponsorship donation will be used to help those ...
(Date:5/26/2020)... ... May 26, 2020 , ... SignatureCare Emergency Center, your friendly neighborhood ... . , The new ER is set to open early June, 2020, and will ... 21315 N SH 130, Bldg.4, Pflugerville, TX. , According to Dr. Aaron Braun ...
(Date:5/26/2020)... ... 26, 2020 , ... Rize Health, an innovative ... provide them with revolutionary clinical trial solutions. , Through this strategic partnership, Rize ... that enables onboarding, scheduling, and remote data capture - right from your fingertips. ...
Breaking Medicine Technology:
(Date:5/26/2020)... ... May 26, 2020 , ... ... unknown mechanism through which certain infections can impact the brain causing post ... Neuropsychiatric Disorders Associated with Streptococcal Infections) and PANS (Pediatric Acute-onset Neuropsychiatric Syndrome) ...
(Date:5/26/2020)... ... 2020 , ... As much of the country continues to ... joining forces to start a country-wide movement of physical activity to honor and ... is a national fitness challenge beginning Tuesday, May 26 and culminating on Sunday, ...
(Date:5/21/2020)... ... May 21, 2020 , ... Summit Medical , ... deliver over one million FDA-compliant face shields — designed, engineered and manufactured in ... critical need for personal protective equipment (PPE) for both front-line health care workers ...
(Date:5/21/2020)... ... 21, 2020 , ... Friends of Lisa Campbell, announce that Lisa Campbell, candidate ... Parenthood Southeast Advocates (PPSEA). PPSEA educates and lobbies on behalf of women’s ... of reproductive health care. PPSEA educates and lobbies on behalf of women’s health and ...
(Date:5/21/2020)... ... May 21, 2020 , ... Casenet® LLC ... platform that supports care management and utilization management at health insurance plans. Developed ... TruCare 2020 provides significant usability and automation upgrades to all of its existing ...
Breaking Medicine News(10 mins):